Fig. 5From: BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltratesCorrelation analysis between BAG3 methylation and KIRC patients based on ULCAN and GSCA database. A Mean methylation levels of the BAG3 promoter in KIEC versus normal tissues in TCGA cohort. B The methylation level of BAG3 between renal clear carcinoma tissues and normal renal tissues. C The correlation between NEIL3 methylation and mRNA expression. D–F The effect of NEIL3 methylation on overall survival (OS), progression-free survival (PFS), disease-specific survival (DSS), and disease-free interval (DFI) of patients with KIRC. **p < 0.01, ***p < 0.001Back to article page